On Friday, Shares of POZEN Inc. (NASDAQ:POZN), lost -0.81% to $11.01.
POZEN Inc., declared the acquisition of Tribute Pharmaceuticals Canada Inc. (“Tribute”) (TSX VENTURE:TRX)(TBUFF), a Canadian specialty pharmaceutical company, in a transaction valued at about US$146 million. Upon completion of the acquisition, which is predictable to occur in the fourth quarter of 2015, the combined company will be named Aralez Pharmaceuticals plc and domiciled in Ireland. Upon closing, Aralez is predictable to trade on NASDAQ and TSX.
The acquisition will create a premier specialty pharmaceutical company with a broad portfolio of commercial products and a growth plan focused on innovative products and acquisitions and the commercialization of portfolio products in the United States and Canada. The Company will also be well positioned to expand its foreign presence through potential international sales and licensing, manufacturing and product development.
POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and pain related conditions in the United States and internationally. Its principal PA product candidates comprise PA32540 and PA8140 for secondary prevention of cardiovascular and cerebrovascular disease in patients at risk for gastric ulcers, which have accomplished clinical development in the United States.
Shares of Expedia Inc (NASDAQ:EXPE), inclined 1.32% to $110.71, during its last trading session.
Expedia Inc, unveiled several major updates to its award-winning Expedia mobile apps, in response to recent company research on mobile travel behaviors. The updates enable a more complete, one-stop travel resource, featuring access to an enormous selection of flights, hotels and now rental cars, in addition to a number of local activity options in top U.S. destinations.
Expedia, Inc., together with its auxiliaries, operates as an online travel company in the United States and internationally. The company operates in two segments, Leisure and Egencia.
Finally, Mentor Graphics Corp (NASDAQ:MENT), ended its last trade with -0.07% loss, and close at $26.86.
Mentor Graphics Corp, declared that it scored a victory over the last remaining patent infringement allegation made against it by Synopsys Inc. (SNPS). The U.S. Patent and Trademark Office has agreed with Mentor Graphics’ assertion that certain claims of U.S. Patent No. 6,836,420 owned by Synopsys, Inc. are un-patentable.
Synopsys had asserted these claims of the ‘420 patent against Mentor Graphics in the Federal District Court for the Northern District of California, alleging that they were infringed by Mentor Graphics emulators and FPGA synthesis tools. These were the only remaining claims at issue in the lawsuit, as the other patents Synopsys also asserted in that lawsuit were formerly invalidated by the District Court.
Mentor Graphics Corporation provides electronic design automation software and hardware solutions to automate the design, analysis, and testing of electro-mechanical systems, electronic hardware, and embedded systems software.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
